UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 1-U

Current Report Pursuant to Regulation A

Date of Report (Date of earliest event reported): July 21, 2022

FUTURE CARDIA, INC.

(Exact name of issuer as specified in its charter)

Nevada	84-1730527
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

910 Woodbridge Court, Safety Harbor, FL 34695

(Full mailing address of principal executive offices)

727-470-3466

(Issuer’s telephone number, including area code)

Title of each class of securities issued pursuant to Regulation A: Common Stock

ITEM 9. OTHER EVENTS.

On July 21, 2022, Oracle Health, Inc. (the “Company”), filed a Certificate of Amendment to Articles of Incorporation of the Company (the “Certificate of Amendment”) with the Secretary of State of the State of Nevada, pursuant to which the Company changed its name to “Future Cardia, Inc.”

The Certificate of Amendment was approved by the holder of approximately 70.2% voting power of the total issued and outstanding capital stock of the Company by written consent on July 15, 2022.  Such approval and consent constitute the approval and consent of at least a majority of the voting power of the Company’s outstanding capital stock and are sufficient under Section 78.320 of the Nevada Revised Statutes and the Company’s Articles of Incorporation and Bylaws then in effect to approve the Certificate of Amendment.

The Certificate of Amendment is attached hereto as Exhibit 2.1 and is incorporated herein by reference.

1

EXHIBITS

Exhibit No.	Description
2.1	Certificate of Amendment to Articles of Incorporation filed with the Secretary of State of State of Nevada on July 21, 2022

2

SIGNATURES

Pursuant to the requirements of Regulation A, the issuer has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Future Cardia, Inc.
Date: July 25, 2022	By:	/s/ Jaeson Bang
	Name:	Jaeson Bang
	Title:	Chief Executive Officer

3